Key result
Sensitivity to hypertension- and dyslipidemia-related lifestyle exposures linked to ~60% higher CVD risk.
Why the study?
Identifying who is most sensitive to adverse lifestyle exposures may help optimize the timing, design, and delivery of preventative interventions for cardiometabolic disease.
Does sensitivity to adverse lifestyle exposures predict cardiometabolic disease later in life in a population-based cohort?
Cohort (n=53,507)
Yes
Does sensitivity to adverse lifestyle exposures predict cardiometabolic disease later in life in a population-based cohort?
A novel quantile random forest approach identifying individuals sensitive to adverse lifestyle exposures predicts higher risk of subsequent cardiovascular events, highlighting a subgroup that may benefit from early preventive interventions.
Answers are grounded in this paper and cite their sources.
May flag a high-risk CVD subgroup for closer monitoring; leaves open whether targeting sensitivity alters outcomes.
who is most sensitive may help optimize the timing, design, and delivery of preventative interventions. We aimed to ascertain a person's degree of resilience or sensitivity to adverse lifestyle exposures and determine whether these classifications help predict cardiometabolic disease later in life; we pooled data from two population-based Swedish prospective cohort studies (n = 53,507), and we contrasted an individual's cardiometabolic biomarker profile with the profile predicted for them given their lifestyle exposure characteristics using a quantile random forest approach. People who were classed as 'sensitive' to hypertension- and dyslipidemia-related lifestyle exposures were at higher risk of developing cardiovascular disease (CVD, hazards ratio 1.6 (95% CI: 1.3, 1.91)), compared with the general population. No differences were observed for type 2 diabetes (T2D) risk. Here, we report a novel approach to identify individuals who are especially sensitive to adverse lifestyle exposures and who are at higher risk of subsequent cardiovascular events. Early preventive interventions may be needed in this subgroup.
No takes yet. Share an insight, caveat, or question.
Pomares‐Millan et al. (2022) conducted a cohort in Cardiometabolic morbidity and mortality (n=53,507). Sensitivity to hypertension- and dyslipidemia-related lifestyle exposures vs. General population was evaluated on Cardiovascular disease (CVD) (HR 1.6, 95% CI 1.3-1.91). Sensitivity to hypertension- and dyslipidemia-related lifestyle exposures was associated with a higher risk of cardiovascular disease compared with the general population.
Synapse has enriched 10 related papers. Consider them for comparative context: